Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 2
2005 1
2006 7
2007 3
2008 3
2009 2
2010 6
2011 5
2012 9
2013 7
2014 7
2015 4
2016 7
2017 5
2018 7
2019 7
2020 12
2021 13
2022 8
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.
van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, Pfister HW, Read RC, Sipahi OR, Brouwer MC; ESCMID Study Group for Infections of the Brain (ESGIB). van de Beek D, et al. Among authors: mourvillier b. Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62. doi: 10.1016/j.cmi.2016.01.007. Epub 2016 Apr 7. Clin Microbiol Infect. 2016. PMID: 27062097 Free article. No abstract available.
Dupont V, Gamblin C, Bard M, Julien G, Bonnivard M, Champenois V, Goury A, Mourvillier B. Dupont V, et al. Among authors: mourvillier b. Chest. 2021 Sep;160(3):e321-e322. doi: 10.1016/j.chest.2021.05.037. Chest. 2021. PMID: 34488982 No abstract available.
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.
Mazeraud A, Jamme M, Mancusi RL, Latroche C, Megarbane B, Siami S, Zarka J, Moneger G, Santoli F, Argaud L, Chillet P, Muller G, Bruel C, Asfar P, Beloncle F, Reignier J, Vinsonneau C, Schimpf C, Amour J, Goulenok C, Lemaitre C, Rohaut B, Mateu P, De Rudnicki S, Mourvillier B, Declercq PL, Schwebel C, Stoclin A, Garnier M, Madeux B, Gaudry S, Bailly K, Lamer C, Aegerter P, Rieu C, Sylla K, Lucas B, Sharshar T. Mazeraud A, et al. Among authors: mourvillier b. Lancet Respir Med. 2022 Feb;10(2):158-166. doi: 10.1016/S2213-2600(21)00440-9. Epub 2021 Nov 11. Lancet Respir Med. 2022. PMID: 34774185 Free PMC article. Clinical Trial.
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Vlaar APJ, Witzenrath M, van Paassen P, Heunks LMA, Mourvillier B, de Bruin S, Lim EHT, Brouwer MC, Tuinman PR, Saraiva JFK, Marx G, Lobo SM, Boldo R, Simon-Campos JA, Cornet AD, Grebenyuk A, Engelbrecht JM, Mukansi M, Jorens PG, Zerbib R, Rückinger S, Pilz K, Guo R, van de Beek D, Riedemann NC; PANAMO study group. Vlaar APJ, et al. Among authors: mourvillier b. Lancet Respir Med. 2022 Dec;10(12):1137-1146. doi: 10.1016/S2213-2600(22)00297-1. Epub 2022 Sep 7. Lancet Respir Med. 2022. PMID: 36087611 Free PMC article. Clinical Trial.
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy study group. Ader F, et al. Among authors: mourvillier b. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26. Clin Microbiol Infect. 2021. PMID: 34048876 Free PMC article. Clinical Trial.
Barbier F, Pommier C, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Souweine B, Zahar JR, Timsit JF; for the OUTCOMEREA Study Group. Barbier F, et al. Among authors: mourvillier b. Intensive Care Med Exp. 2015 Oct 1;3 Suppl 1(Suppl 1):A1-A1021. doi: 10.1186/2197-425x-3-s1-a1. Intensive Care Med Exp. 2015. PMID: 27419821 Free PMC article. No abstract available.
[Emerging azole antifungals].
Wolff M, Bouadma L, Mourvillier B. Wolff M, et al. Among authors: mourvillier b. Therapie. 2006 May-Jun;61(3):227-33. doi: 10.2515/therapie:2006039. Therapie. 2006. PMID: 16989123 Review. French.
Treatment of bloodstream infections in ICUs.
Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, Mourvillier B, Sonneville R, Mariotte E, Bouadma L, Wolff M. Timsit JF, et al. Among authors: mourvillier b. BMC Infect Dis. 2014 Nov 28;14:489. doi: 10.1186/1471-2334-14-489. BMC Infect Dis. 2014. PMID: 25431091 Free PMC article. Review.
Management of severe imported malaria in adults.
Bruneel F, Raffetin A, Corne P, Llitjos JF, Mourvillier B, Argaud L, Wolff M, Laurent V, Jauréguiberry S. Bruneel F, et al. Among authors: mourvillier b. Med Mal Infect. 2020 Mar;50(2):213-225. doi: 10.1016/j.medmal.2018.08.003. Epub 2018 Sep 25. Med Mal Infect. 2020. PMID: 30266432
108 results